SHR1701 in combination with Surufatinib as late-line treatment in advanced colorectal cancer
Ontology highlight
ABSTRACT: Interventions: dose-exploration :SHR1701 and Surufatinib;dose-expansion:SHR1701 and Surufatinib
Primary outcome(s): Objective response rate
Study Design: Single arm
DISEASE(S): Colorectal Cancer
PROVIDER: 88738 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA